These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 35912100)

  • 1. Connecting Metabolic Rewiring With Phenotype Switching in Melanoma.
    Falletta P; Goding CR; Vivas-García Y
    Front Cell Dev Biol; 2022; 10():930250. PubMed ID: 35912100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
    Vivas-García Y; Falletta P; Liebing J; Louphrasitthiphol P; Feng Y; Chauhan J; Scott DA; Glodde N; Chocarro-Calvo A; Bonham S; Osterman AL; Fischer R; Ronai Z; García-Jiménez C; Hölzel M; Goding CR
    Mol Cell; 2020 Jan; 77(1):120-137.e9. PubMed ID: 31733993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
    Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
    Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.
    Najem A; Soumoy L; Sabbah M; Krayem M; Awada A; Journe F; Ghanem GE
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives.
    Pellerin L; Carrié L; Dufau C; Nieto L; Ségui B; Levade T; Riond J; Andrieu-Abadie N
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironment-derived factors driving metastatic plasticity in melanoma.
    Kim IS; Heilmann S; Kansler ER; Zhang Y; Zimmer M; Ratnakumar K; Bowman RL; Simon-Vermot T; Fennell M; Garippa R; Lu L; Lee W; Hollmann T; Xavier JB; White RM
    Nat Commun; 2017 Feb; 8():14343. PubMed ID: 28181494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.
    Ahmed F; Haass NK
    Front Oncol; 2018; 8():173. PubMed ID: 29881716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
    Hossain SM; Eccles MR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic rewiring in melanoma drug-resistant cells.
    Bristot IJ; Kehl Dias C; Chapola H; Parsons RB; Klamt F
    Crit Rev Oncol Hematol; 2020 Sep; 153():102995. PubMed ID: 32569852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation.
    Guendisch U; Loos B; Cheng PF; Dummer R; Levesque MP; Varum S; Sommer L
    Front Cell Dev Biol; 2022; 10():916033. PubMed ID: 35693944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity.
    Vandamme N; Berx G
    Front Oncol; 2014; 4():352. PubMed ID: 25538895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cellular hierarchy in melanoma uncouples growth and metastasis.
    Karras P; Bordeu I; Pozniak J; Nowosad A; Pazzi C; Van Raemdonck N; Landeloos E; Van Herck Y; Pedri D; Bervoets G; Makhzami S; Khoo JH; Pavie B; Lamote J; Marin-Bejar O; Dewaele M; Liang H; Zhang X; Hua Y; Wouters J; Browaeys R; Bergers G; Saeys Y; Bosisio F; van den Oord J; Lambrechts D; Rustgi AK; Bechter O; Blanpain C; Simons BD; Rambow F; Marine JC
    Nature; 2022 Oct; 610(7930):190-198. PubMed ID: 36131018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report.
    Eichhoff OM; Zipser MC; Xu M; Weeraratna AT; Mihic D; Dummer R; Hoek KS
    Melanoma Res; 2010 Aug; 20(4):349-55. PubMed ID: 20526217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.
    Correnti M; Binatti E; Gammella E; Invernizzi P; Recalcati S
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative behaviour and phenotype plasticity evolve during melanoma progression.
    Rowling EJ; Miskolczi Z; Nagaraju R; Wilcock DJ; Wang P; Telfer B; Li Y; Lasheras-Otero I; Redondo-Muñoz M; Sharrocks AD; Arozarena I; Wellbrock C
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):695-708. PubMed ID: 32145051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells versus phenotype-switching in melanoma.
    Hoek KS; Goding CR
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):746-59. PubMed ID: 20726948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic rewiring directs melanoma immunology.
    Sun N; Tian Y; Chen Y; Guo W; Li C
    Front Immunol; 2022; 13():909580. PubMed ID: 36003368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance.
    Belisario DC; Kopecka J; Pasino M; Akman M; De Smaele E; Donadelli M; Riganti C
    Cells; 2020 Dec; 9(12):. PubMed ID: 33291643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.
    Rambow F; Marine JC; Goding CR
    Genes Dev; 2019 Oct; 33(19-20):1295-1318. PubMed ID: 31575676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.